Cost-effectiveness of eptifibatide in patients undergoing planned coronary stenting: Results from the ESPRIT trial

被引：0
|
作者：
Cohen, DJ
Cosgrove, RS
Berezin, RH
O'Shea, J
Kitt, MM
Gilchrist, I
Mark, DB
Tcheng, JE
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Clin Res Inst, Boston, MA USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Cor Therapeut, San Francisco, CA USA
[5] Penn State Univ, Coll Med, College Stn, PA USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1841
引用
收藏
页码：386 / 387
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany
    Dewilde, Sarah
    Brueggenjuergen, Bernd
    Nienaber, Christoph
    Senges, Jochen
    Welte, Robert
    Willich, Stefan N.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (04): : 381 - 391
  • [2] Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany
    Sarah Dewilde
    Bernd Brüggenjürgen
    Christoph Nienaber
    Jochen Senges
    Robert Welte
    Stefan N. Willich
    The European Journal of Health Economics, 2012, 13 : 381 - 391
  • [3] Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial
    Bakhai, A
    Stone, GW
    Murphy, SA
    Githiora, L
    Berezin, RH
    Gedney, S
    Hormel, P
    Effron, M
    Cox, DA
    Tcheng, JE
    Grines, CL
    Cohen, DJ
    CIRCULATION, 2002, 106 (19) : 518 - 518
  • [4] Cost-effectiveness of eptifibatide in patients undergoing percutaneous coronary intervention in Germany
    Dewilde, S.
    Bruggenjurgen, B.
    Welte, R.
    Willich, S. N.
    VALUE IN HEALTH, 2006, 9 (06) : A192 - A192
  • [5] High-dose eptifibatide in elective coronary stenting: Results of the ESPRIT trial
    Tcheng, JE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 321 - 321
  • [6] The cost-effectiveness of coronary stenting in acute myocardial infarction: Results from the Stent-PAMI trial
    Cohen, DJ
    Taira, DA
    Berezin, RA
    Jones, N
    Cox, DA
    Brodie, BR
    Morice, MC
    Stone, GW
    Grines, CL
    CIRCULATION, 1999, 100 (18) : 87 - 88
  • [7] Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT trial)
    Reddan, DN
    O'Shea, JC
    Sarembock, IJ
    Williams, KA
    Pieper, KS
    Santoian, E
    Owen, WF
    Kitt, MM
    Tcheng, JE
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (01): : 17 - 21
  • [8] Effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, among diabetic patients following coronary stenting: Results from ESPRIT
    Labinaz, M
    Madan, M
    McGuire, DK
    Batchelor, W
    Saucedo, J
    Pacchiana, C
    Kitt, MM
    O'Shea, JC
    Talley, DJ
    Liu, H
    Timmis, S
    Tcheng, JE
    CIRCULATION, 2000, 102 (18) : 665 - +
  • [9] Cost-effectiveness of eptifibatide in NSTEMI patients in Poland
    Dewilde, S
    Opolski, G
    Brown, R
    VALUE IN HEALTH, 2005, 8 (06) : A111 - A112
  • [10] Cost-effectiveness of abciximab and stenting in acute myocardial infarction: Results from the CADILLAC trial
    Cohen, DJ
    Grines, C
    Cox, D
    Stuckey, T
    Carroll, J
    Griffin, J
    Cosgrove, RS
    Githiora, L
    Berezin, RH
    Tcheng, J
    Stone, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 31A - 31A
12345